3-(2-Furyl)propionic acid structure
|
Common Name | 3-(2-Furyl)propionic acid | ||
---|---|---|---|---|
CAS Number | 935-13-7 | Molecular Weight | 140.14 | |
Density | 1.206 g/cm3 | Boiling Point | 229 | |
Molecular Formula | C7H8O3 | Melting Point | 56-59 °C | |
MSDS | Chinese USA | Flash Point | 103ºC | |
Symbol |
GHS05, GHS07 |
Signal Word | Danger |
Name | 3-(2-furyl)propanoic acid |
---|---|
Synonym | More Synonyms |
Density | 1.206 g/cm3 |
---|---|
Boiling Point | 229 |
Melting Point | 56-59 °C |
Molecular Formula | C7H8O3 |
Molecular Weight | 140.14 |
Flash Point | 103ºC |
PSA | 50.44000 |
LogP | 1.29680 |
Storage condition | Refrigerator (+4°C) |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H315-H318-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R37/38;R41 |
Safety Phrases | S37/39-S26-S39 |
RIDADR | NONH for all modes of transport |
HS Code | 2932190090 |
Precursor 10 | |
---|---|
DownStream 6 | |
HS Code | 2932190090 |
---|---|
Summary | 2932190090 other compounds containing an unfused furan ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |
Diels-Alder hydrogels with enhanced stability: First step toward controlled release of bevacizumab.
Eur. J. Pharm. Biopharm. 96 , 217-25, (2015) Eight-armed PEG was functionalized with furyl and maleimide groups (8armPEG20k-Fur and 8armPEG20k-Mal); degradable hydrogels were obtained by cross-linking via Diels-Alder chemistry. To increase the s... |
|
Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
J. Pharm. Pharm. Sci. 17(4) , 475-84, (2015) Organic anion-transporting polypeptide (OATP) 1B1 and OATP1B3 contribute to hepatic uptake of numerous drugs. Thus, reduced OATP1B1 and OATP1B3 activity in chronic kidney disease (CKD) may have a majo... |
3-(furan-2-yl)propanoic acid |
EINECS 213-298-4 |
2-Furanpropanoic acid, ion(1-) |
3-(2-Furyl)propanoate |
MFCD00005346 |
3-(2-Furyl)propionic acid |